One of a select number of clinical centers in 12 major U.S. markets to offer this breakthrough technology
The Argus II is the first and only “bionic eye” to be approved in countries throughout the world, including the U.S. It is used to treat patients with late stage retinitis pigmentosa (RP). Argus II was developed by Second Sight Medical Products, Inc., located near Los Angeles.
In preparation for the launch of Argus II later this year, implanting centers, including UH, will soon begin to accept consultations for patients with RP. UH is one of a select number of medical centers in 12 major markets in the nation, and the only one in Cleveland and the state of Ohio, chosen by Second Sight to offer the Argus II, which received FDA approval earlier this year.
Argus II works by converting video images captured by a miniature camera, housed in the patient’s glasses, into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes on the surface of the retina. These pulses are intended to stimulate the retina’s remaining cells resulting in the corresponding perception of patterns of light in the brain. Patients then learn to interpret these visual patterns thereby regaining some visual function.
“This is a remarkable breakthrough,” said Suber S. Huang, MD, MBA, Director, UH Eye Institute’s Center for Retina and Macular Disease, who also served as the Independent Medical Safety Monitor for clinical trials of the system and gave the summary closing to the FDA Ophthalmic devices panel.
“The system offers a profound benefit for people who are blind from RP and who currently have no therapy available to them. Argus II allows patients to reclaim their independence and improve their lives.”
RP is a rare inherited, degenerative eye disease that often results in profound vision loss to the level of bare light perception or no light perception. It affects nearly 100,000 Americans. Noted Cleveland businessman and professional sports owner Gordon Gund is blind from this disease.
“We are thrilled that several of the nation’s top hospitals will be the first to offer Argus II to patients in the U.S.,” said Brian Mech, Vice President of Business Development, Second Sight. “After an intensive and difficult selection process, these sites were chosen for their cutting-edge approach to medicine and unparalleled commitment to patient care. We are confident that RP patients seeking treatment at these centers will benefit greatly from the best-in-class services these sites provide.”
Argus II had more than 20 years of work in the field, three clinical trials, more than $100 million in public investment by the National Eye Institute, the Department of Energy, and the National Science Foundation, and an additional $100 million in private investment.
The Latest Bing News on:
- Apple Event Live Blog: Key AAPL Stock Takeawayson October 13, 2020 at 11:04 am
Not sure what the iPhone 12 means for AAPL stock? Follow the Apple event in real time with InvestorPlace for investing takeaways.
- Global Bionic Eye Market Analysis and Forecast Report 2020-2026 - ResearchAndMarkets.comon October 13, 2020 at 8:44 am
The "Global Bionic Eye Market by Technology, by End Use, by Type, by Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
- Dan Haar: ‘Bionic man’ of the Senate outlasts everyoneon October 12, 2020 at 5:24 pm
Tem Martin Looney needed a kidney transplant and hip replacement in 2016, and had already served in the General Assembly for 36 years.
- Early Snapdragon 875 Benchmark Score Fails To Overtake A13 Bionicon October 12, 2020 at 2:59 pm
Early benchmark tests for Qualcomm Snapdragon 875 reveals that it is not powerful to beat even Apple's A13 Bionic chip from last year.
- Apple on designing the A14 Bionic for the iPad Air and beyondon October 12, 2020 at 10:37 am
No, it’s what the new Air had lurking inside that slim frame. To our surprise, the 2020 iPad Air was the first device announced by Apple to use the new A14 Bionic chipset. That silicon’s impact won't ...
- Are Bionic Cornea The Next Frontier In Human Bionics?on October 9, 2020 at 7:54 am
Bionic limbs have been entering the mainstream for a number of years, helping to improve the lives of people with limb difference.
- Pocketnow Daily: Apple iPhone 12 Event Teaser is INTERESTING? (video)on October 1, 2020 at 5:45 pm
On today's Pocketnow Daily, we talk about the official date for the next Apple event, some Apple devices we can expect, and more.
- Global Bionic Eye Market Size 2020 Research Findings, Market Growth Factors Analysis and Forecasts – 2026on September 27, 2020 at 4:48 pm
Sep 27, 2020 (The Expresswire) -- 2020 Bionic Eye Market:- Bionic Eye is an experimental visual device intended to restore functional vision in those suffering from partial or total blindness.
- First human clinical trials involving a bionic eye set to beginon September 22, 2020 at 3:05 pm
Bionic eye with sharper vision than real eye could be ready in just five years, experts say Little girl names dead beetle that was in her eye for 9 hours Coronavirus can enter the body through the ...
- Doctors Are Preparing to Implant the World’s First Human Bionic Eyeon September 15, 2020 at 11:34 pm
The team is now preparing for what they claim will be the world’s first human clinical trials of a bionic eye — and are asking for additional funding to eventually manufacture it on a global ...
The Latest Google Headlines on:
The Latest Bing News on:
- Bionic Senseson October 9, 2020 at 5:00 pm
These are notable for the fact that they are not merely high-tech prosthetic replacements strapped ... The Argus II Retinal Stimulation System is biotech firm Second Sight’s bionic eye, and ...
- Retinal Surgery Devices Marketon October 5, 2020 at 5:51 am
The Retinal Surgery Devices market report by Reports and Data provides an extensive overview of the vital elements of the Retinal Surgery Devices market and factors such as the drivers ...
- Implants for Artificial Visionon October 1, 2020 at 5:00 pm
Will retinal implants be superior to molecular ... the stimulation paradigms can be more easily programmed. In cortical prosthesis, depending on the depth of the stimulating electrodes and the ...
- Retinitis Pigmentosa News and Researchon September 29, 2020 at 5:00 pm
Researchers at IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology) has led to the revolutionary development of an artificial liquid retinal prosthesis to counteract the effects ...
- Real neurons are noisy. Can neural implants figure that out?on September 15, 2020 at 10:08 am
"To make an ideal retinal prosthetic (a bionic eye), it would probably need to incorporate these noise correlations for the brain to correctly interpret the signals it receives from the prosthetic ...
- Real Neurons are Noisy. Can Neural Implants Figure That Out?on September 15, 2020 at 9:30 am
The brain’s visual centers must be adept at filtering out the noise from the retinal cells to get to the true signal, and those filters have to constantly adapt to light conditions to keep the signal ...
- System Bits: Aug. 29on August 28, 2020 at 5:00 pm
Palanker’s new prosthetic device, called PRIMA, is being commercialized in partnership with Pixium Vision of France. Like a different retinal system, the ARGUS II, it features a tiny video camera ...
- Artificial retina co-developer Mark Humayun explains the retinal prosthesis.on July 12, 2020 at 10:34 pm
This material is available primarily for archival purposes. Telephone numbers or other contact information may be out of date; please see current contact information at media contacts.